JPRN-jRCT1031190025
Completed
Phase 4
Comparison study to evaluate the effect of denosumab or alendronate sodium hydrate on coronary artery calcification score for osteoporosis with complications of coronary artery disease
Kubota Naoki0 sites1 target enrollmentMay 20, 2019
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Patients with osteoporosis with coronary artery calcification
- Sponsor
- Kubota Naoki
- Enrollment
- 1
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
This study was suspended due to difficulty in securing the required number of patients.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients (\>20 years old) with osteoporosis with coronary artery calcification
Exclusion Criteria
- •Patients who can not enforce coronary artery CT, patients with baseline coronary calcification score of 0 or 1000 or more, secondary osteoporosis patients, patients with severe renal impairment(eGFR\<35mL/min).
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Cohort study evaluating the efficacy of denosumab to protect against aromatase inhibitor-induced bone loss in Japanese breast cancer patients.JPRN-UMIN000014954CYBORG (Chiba Youth Breast Oncology Research Group)500
Completed
Not Applicable
Study for necessity of insulin treatment in two enteral feeding formulas which are different in carbohydrates and fatty acids concentrations in tube-fed subjects with type 2 diabetes mellitustype 2 diabetes mellitus, Cerebral vascular diseaseJPRN-UMIN000001784Saiseikai Central Hospital40
Completed
Phase 2
Efficacy and safety of weekly nab-paclitaxel plus CBDCA in patients with CUPcancer of unknown primaryCUP, nab-Paclitaxel,CBDCAJPRN-jRCTs051180084Yagi Toshinari17
Recruiting
Not Applicable
Clinical trial of 3,4-diaminopyridine(3,4-DAP) for the Lambert-Eaton myasthenic syndromeambert-Eaton myasthenic syndrome(LEMS)JPRN-UMIN000029085Gunma university graduate school of medicine1
Completed
Not Applicable
Correlation analysis between pouchitis disease activity and measuring fecal concentration of calprotectipouchitisJPRN-UMIN000014915Hyogo College of Medicine15